Moderna COVID-19 Vaccine Shows Immunogenicity in Older Patients

August 28, 2020

https://www.genengnews.com/news/moderna-covid-19-vaccine-shows-immunogenicity-in-older-patients/?utm_medium=newsletter&utm_source=GEN+Daily+News+Highlights&utm_content=01&utm_campaign=GEN+Daily+News+Highlights_20200827&oly_enc_id=1683D5283356B3U

Very encouraging results on this vaccine so far. The antibody response is better than the best convalescent plasma antibody titers. The vaccine also elicits T cell response that bodes well for durability of protection. But they still need to complete the randomized,
placebo-controlled trial to see if the vaccine actually is both safe and effective (latter is defined as lower number of symptomatic Covid infections in vaccinated vs placebo subjects.